Table 1.
Patient details
Patient | Age (years) | Sex | Tissue | Time (years) since previous episode | Duration of pre-operative treatment (months) |
---|---|---|---|---|---|
A 1–7 | 42 ± 14 | F | L (TB) | Np-24 | 0–12 |
A8–10 | 40 ± 6 | M | L (TB) | Np | 0–4 |
A11–14 | 36 ± 10 | F | L (S) | 0 | 0 |
A15–19 | 35 ± 8 | M | L (S) | 0 | 0 |
C1–2 | 3 and 6 | F | L (TB) | 2 and Np | 6 |
C3 | 7 | M | L (TB) | 5 | 2 |
C4–5 | 2 and 8 | F | LN (TB) | Np | 4–5 days |
C6–10 | 4 ± 2 | M | LN (TB) | Np | 0–20 days |
Pre-operative treatment included rifampicin, isoniazid and pyrazinamide. Age is mean ± SEM. C, child; A, adult; F, female; M, male; L, lung; LN, lymph node; TB, tuberculosis; S, sarcoid; Np, no previous episode.